Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm

Colo-rectal Cancer Clinical Trial

Official title: Randomized Controlled Trial Investigating Use of Submucosal Injection of EverLift in Rates of Complete Resection of Nonpedunculated Polyps 4-9mm

Status Completed

Clinical Trial Summary

The focus of the study is to evaluate impact of submucosal injection of EverLift in achieving complete resection during polypectomy of polyps 4-9mm during colonoscopy.

Clinical Trial Description

The details of the proposed study are as follows:

1. Experimental group: using EverLift submucosal injection for polyps 4-9mm of the colon

2. Control group: not using EverLift submucosal injection for polyps 4-9mm of the colon

3. Methods:

1. Colonoscopy will be performed in the same standard of care manner as if no study was taking place.

2. If polyps 4-9mm are identified, the endoscopist is randomized to performing polypectomy with or without submucosal injection of EverLift.

3. After removal of the polypectomy, two biopsies are performed at the margin of the polypectomy site to identify residual lesion.

4. The polyp as well as well as the two biopsies are reviewed by a pathologist. ;

Related Conditions & MeSH terms

• Adenomatous Polyp of Colon
• Adenomatous Polyps
• Colo-rectal Cancer
• Colonic Polyps
• Polyp of Colon
• Polyps

• NCT number: NCT04551014
• Study type: Interventional
• Source: Stanford University
• Status: Completed
• Phase: N/A
• Start date: September 16, 2020
• Completion date: July 15, 2021